189 related articles for article (PubMed ID: 9334398)
1. Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims.
Staley JK; Rothman RB; Rice KC; Partilla J; Mash DC
J Neurosci; 1997 Nov; 17(21):8225-33. PubMed ID: 9334398
[TBL] [Abstract][Full Text] [Related]
2. D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims.
Mash DC; Staley JK
Ann N Y Acad Sci; 1999 Jun; 877():507-22. PubMed ID: 10415668
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
4. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
[TBL] [Abstract][Full Text] [Related]
5. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB
Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593
[TBL] [Abstract][Full Text] [Related]
6. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
7. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
Schroeder JA; Niculescu M; Unterwald EM
Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
9. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.
Quirion R; Pilapil C; Magnan J
Cell Mol Neurobiol; 1987 Sep; 7(3):303-7. PubMed ID: 2830975
[TBL] [Abstract][Full Text] [Related]
10. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
[TBL] [Abstract][Full Text] [Related]
11. Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences.
Rothman RB; Bykov V; Xue BG; Xu H; De Costa BR; Jacobson AE; Rice KC; Kleinman JE; Brady LS
Peptides; 1992; 13(5):977-87. PubMed ID: 1336192
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
13. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
Morris BJ; Herz A
Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
[TBL] [Abstract][Full Text] [Related]
15. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats.
Maisonneuve IM; Archer S; Glick SD
Neurosci Lett; 1994 Nov; 181(1-2):57-60. PubMed ID: 7898771
[TBL] [Abstract][Full Text] [Related]
16. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
Horan P; de Costa BR; Rice KC; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
19. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
